Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Dr Sarah Harris qualified from King's College Hospital in 1989. She worked as Consultant Clinical Oncologist at Guys and St Thomas Hospitals for 20 years from 1998 until July 2019, specialising in the treatment of breast and prostate cancer using drug treatments/radiotherapy. Her main interest is technical radiotherapy. She now works in Harley Street specialising in the treatment of breast and prostate cancer using advanced radiotherapy techniques including IMRT, IGRT and breath-hold for left-sided breast radiotherapy. She has trained and uses cyberknife and stereotactic body radiotherapy for the treatment of limited secondary cancers. She also trained in using proton beam therapy as an innovative radiotherapy treatment method, to treat certain types of cancers.
Dr Sarah Harris has recruited patients and followed up patients in all of the UK breast and prostate radiotherapy trials over the past 20 years.
Proton Beam Therapy
This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.